Development of Capillary Electrophoresis Technique for Simultaneous Measurement of Amlodipine and Atorvastatin from Their Combination Drug Formulations
- 12 November 2009
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 32 (20) , 2923-2942
Abstract
A simple, accurate, precise, and sensitive capillary electrophoresis (CE) technique coupled to a diode array detector (DAD) has been developed for the separation and simultaneous determination of amlodipine (AM) and atorvastatin (AT) from their combination formulations. The proposed method utilized fused silica capillary (50 cm × 75 µm ID) and background electrolyte (BGE) composed of phosphate buffer (pH 6.5, 25 mM)-methanol, (80:20, v/v). The separation was achieved at 15 KV applied voltage and 25°C. Losartan was chosen as the internal standard to guarantee a high level of quantitative performance. The two drugs were subjected to thermal, photolytic, hydrolytic, and oxidative stress conditions and the stressed samples were analyzed by the proposed method. The method has shown adequate separation for AM and AT from its main degradation products (UK-55-410) & (PD 0162910-00), respectively, which demonstrated the specificity of the assay. The described method was linear over the range of 1 – 50 µg/mL (r = 0.9998) for both drugs (2.4 × 10−6 − 1.2 × 10−4 M for AM and 1.8 × 10−6 −8.6 × 10−5 M for AT). Intra- and inter-day RSD (n = 6) was ≤2.2%. The limits of detection for AM and AT were 0.5 µg/mL. The percentage recoveries (n = 6) of the two drugs from their tablet formulations were 99.97 ± 1.84 and 100.96 ± 1.12, respectively. Degradation products produced as a result of stress studies did not interfere with the detection of AM and AT and the assay can thus be considered stability indicating.Keywords
This publication has 25 references indexed in Scilit:
- Development of a stability‐indicating CE assay for the determination of amlodipine enantiomers in commercial tabletsElectrophoresis, 2008
- Validation of a capillary zone electrophoresis method for the comparative determination of etoricoxib in pharmaceutical formulationsJournal of Separation Science, 2008
- Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detectionJournal of Chromatography B, 2005
- Analysis of five HMG‐CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studiesBiomedical Chromatography, 2005
- Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC–tandem MSAnalytical and Bioanalytical Chemistry, 2005
- Simple, sensitive and rapid LC–MS/MS method for the quantitation of cerivastatin in human plasma — application to pharmacokinetic studiesJournal of Pharmaceutical and Biomedical Analysis, 2004
- A capillary zone electrophoresis (CZE) method for the determination of cyclizine hydrochloride in tablets and suppositoriesJournal of Pharmaceutical and Biomedical Analysis, 2004
- An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tabletsJournal of Pharmaceutical and Biomedical Analysis, 2003
- Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometryRapid Communications in Mass Spectrometry, 1999
- Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasmaJournal of the American Society for Mass Spectrometry, 1999